Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1994 February; 87(2): 63–65.
PMCID: PMC1294315

Antiplatelet therapy following coronary artery surgery.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (722K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Braunwald E. Effects of coronary-artery bypass grafting on survival. Implications of the randomized coronary-artery surgery study. N Engl J Med. 1983 Nov 10;309(19):1181–1184. [PubMed]
  • Lüscher TF. Vascular biology of coronary bypass grafts. Curr Opin Cardiol. 1991 Dec;6(6):868–876. [PubMed]
  • Angelini GD, Bryan AJ. Extending the use of autologous arterial conduits in myocardial revascularisation. Br Heart J. 1992 Aug;68(2):161–162. [PMC free article] [PubMed]
  • Angelini GD, Bryan AJ, West RR, Newby AC, Breckenridge IM. Coronary artery bypass surgery: current practice in the United Kingdom. Thorax. 1989 Sep;44(9):721–724. [PMC free article] [PubMed]
  • Assad-Morell JL, Frye RL, Connolly DC, Davis GD, Pluth JR, Wallace RB, Barnhorst DA, Elveback LR, Danielson GK. Aorta-coronary artery saphenous vein bypass surgery: clinical and angiographic results. Mayo Clin Proc. 1975 Jul;50(7):379–386. [PubMed]
  • Fuchs JC, Mitchener JS, 3rd, Hagen PO. Postoperative changes in autologous vein grafts. Ann Surg. 1978 Jul;188(1):1–15. [PubMed]
  • Josa M, Lie JT, Bianco RL, Kaye MP. Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol. 1981 Jun;47(6):1248–1254. [PubMed]
  • Pfisterer M, Burkart F, Jockers G, Meyer B, Regenass S, Burckhardt D, Schmitt HE, Müller-Brand J, Skarvan K, Stulz P. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Lancet. 1989 Jul 1;2(8653):1–7. [PubMed]
  • Metke MP, Lie JT, Fuster V, Josa M, Kaye MP. Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol. 1979 Jun;43(6):1144–1148. [PubMed]
  • Fuster V, Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation. 1986 Feb;73(2):227–232. [PubMed]
  • Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987 Jun 19;257(23):3233–3240. [PubMed]
  • Verstraete M, Brown BG, Chesebro JH, Ekeström S, Harker LA, Henderson AH, Jewitt DE, Oliver MF, Sleight P. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J. 1986 Jan;7(1):4–13. [PubMed]
  • Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation. 1988 Jun;77(6):1324–1332. [PubMed]
  • Brown BG, Cukingnan RA, DeRouen T, Goede LV, Wong M, Fee HJ, Roth JA, Carey JS. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation. 1985 Jul;72(1):138–146. [PubMed]
  • Sanz G, Pajarón A, Alegría E, Coello I, Cardona M, Fournier JA, Gómez-Recio M, Ruano J, Hidalgo R, Medina A, et al. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC) Circulation. 1990 Sep;82(3):765–773. [PubMed]
  • Lorenz RL, Schacky CV, Weber M, Meister W, Kotzur J, Reichardt B, Theisen K, Weber PC. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet. 1984 Jun 9;1(8389):1261–1264. [PubMed]
  • Catinella FP, Cunningham JN, Jr, Srungaram RK, Baumann FG, Nathan IM, Glassman EA, Knopp EA, Spencer FC. The factors influencing early patency of coronary artery bypass vein grafts: correlation of angiographic and ultrastructural findings. J Thorac Cardiovasc Surg. 1982 May;83(5):686–700. [PubMed]
  • Pantely GA, Goodnight SH, Jr, Rahimtoola SH, Harlan BJ, DeMots H, Calvin L, Rösch J. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. N Engl J Med. 1979 Nov 1;301(18):962–966. [PubMed]
  • Henderson WG, Goldman S, Copeland JG, Moritz TE, Harker LA. Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A meta-analysis of clinical trials. Ann Intern Med. 1989 Nov 1;111(9):743–750. [PubMed]
  • Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol. 1990 Jan;15(1):15–20. [PubMed]
  • Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S, et al. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group. Circulation. 1991 Aug;84(2):520–526. [PubMed]
  • Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation. 1991 May;83(5):1526–1533. [PubMed]
  • Frick MH, Valle M, Harjola PT. Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol. 1983 Oct 1;52(7):681–685. [PubMed]
  • Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med. 1992 Jul 16;327(3):175–181. [PubMed]
  • Underwood MJ, Pringle S, de Bono DP. Reduction of thrombus formation in vivo using a thrombolytic agent targeted at damaged endothelial cells. Br J Surg. 1992 Sep;79(9):915–917. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press